PACAP signaling is not involved in GTN- and levcromakalim-induced hypersensitivity in mouse models of migraine
Abstract Background Calcitonin gene-related peptide (CGRP) antagonizing drugs represents the most important advance in migraine therapy for decades. However, these new drugs are only effective in 50–60% of patients. Recent studies have shown that the pituitary adenylate cyclase-activating peptide (P...
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado em: |
BMC
2022-12-01
|
| coleção: | The Journal of Headache and Pain |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s10194-022-01523-8 |